TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs7501939
log Bayes Factor = 23.6632
Chromosome 17   position 36,101,156  (GRCh37) Explore rs7501939 on Ensembl!
Variant rs7501939 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
Z85.4 Personal history of malignant neoplasm of genital organs
0.000 0.000 1.000
C61 Malignant neoplasm of prostate
0.000 0.000 1.000
E11.9 Without complications
0.998 0.002 0.000
E11.3 With ophthalmic complications
0.995 0.005 0.000
E11 Non-insulin-dependent diabetes mellitus
0.995 0.005 0.000
E11.4 With neurological complications
0.849 0.151 0.000
E11.6 With other specified complications
0.777 0.223 0.000
E11.8 With unspecified complications
0.772 0.228 0.000
C60-C63 Malignant neoplasms of male genital organs
0.000 0.229 0.771
E11.7 With multiple complications
0.770 0.229 0.000
C62 Malignant neoplasm of testis
0.000 0.283 0.717
N40 Hyperplasia of prostate
0.000 0.289 0.711
C62.9 Testis, unspecified
0.000 0.319 0.681
C60 Malignant neoplasm of penis
0.000 0.392 0.608
E11.0 With coma
0.585 0.414 0.000
E11.1 With ketoacidosis
0.580 0.420 0.000
C60.9 Penis, unspecified
0.000 0.475 0.525
C63 Malignant neoplasm of other and unspecified male genital organs
0.000 0.480 0.520
C62.0 Undescended testis
0.000 0.486 0.514
C62.1 Descended testis
0.000 0.503 0.497
C60.8 Overlapping lesion of penis
0.000 0.564 0.436
C60.2 Body of penis
0.000 0.564 0.436
C60.0 Prepuce
0.000 0.564 0.436
E10-E14 Diabetes mellitus
0.407 0.593 0.000
C63.9 Male genital organ, unspecified
0.000 0.627 0.373
C63.8 Overlapping lesion of male genital organs
0.000 0.627 0.373
C63.7 Other specified male genital organs
0.000 0.627 0.373
C63.1 Spermatic cord
0.000 0.627 0.373
C63.0 Epididymis
0.000 0.627 0.373
C60.1 Glans penis
0.000 0.632 0.368
E11.5 With peripheral circulatory complications
0.343 0.657 0.000
C63.2 Scrotum
0.000 0.659 0.341
E11.2 With renal complications
0.296 0.704 0.000
E12 Malnutrition-related diabetes mellitus
0.292 0.708 0.000
E14 Unspecified diabetes mellitus
0.291 0.709 0.000
E13 Other specified diabetes mellitus
0.281 0.719 0.000
E10 Insulin-dependent diabetes mellitus
0.268 0.732 0.000
E14.3 With ophthalmic complications
0.264 0.736 0.000
E14.6 With other specified complications
0.247 0.753 0.000
E10.3 With ophthalmic complications
0.244 0.756 0.000
E10.2 With renal complications
0.222 0.778 0.000
E10.4 With neurological complications
0.217 0.783 0.000
E14.5 With peripheral circulatory complications
0.217 0.783 0.000
E14.4 With neurological complications
0.213 0.787 0.000
E10.8 With unspecified complications
0.211 0.789 0.000
E12.9 Without complications
0.209 0.791 0.000
E12.8 With unspecified complications
0.209 0.791 0.000
E12.7 With multiple complications
0.209 0.791 0.000
E12.6 With other specified complications
0.209 0.791 0.000
E12.5 With peripheral circulatory complications
0.209 0.791 0.000
E12.4 With neurological complications
0.209 0.791 0.000
E12.3 With ophthalmic complications
0.209 0.791 0.000
E12.2 With renal complications
0.209 0.791 0.000
E12.1 With ketoacidosis
0.209 0.791 0.000
E12.0 With coma
0.209 0.791 0.000
E14.7 With multiple complications
0.209 0.791 0.000
E14.0 With coma
0.209 0.791 0.000
E13.8 With unspecified complications
0.202 0.798 0.000
E13.7 With multiple complications
0.202 0.798 0.000
E13.6 With other specified complications
0.202 0.798 0.000
E13.5 With peripheral circulatory complications
0.202 0.798 0.000
E13.4 With neurological complications
0.202 0.798 0.000
E13.2 With renal complications
0.202 0.798 0.000
E13.1 With ketoacidosis
0.202 0.798 0.000
E13.0 With coma
0.202 0.798 0.000
E13.9 Without complications
0.200 0.800 0.000
E13.3 With ophthalmic complications
0.193 0.807 0.000
E14.8 With unspecified complications
0.189 0.811 0.000
E14.1 With ketoacidosis
0.187 0.813 0.000
E10.7 With multiple complications
0.183 0.817 0.000
E10.5 With peripheral circulatory complications
0.180 0.820 0.000
E10.1 With ketoacidosis
0.175 0.825 0.000
E14.2 Withrenal complications
0.169 0.830 0.000
E10.0 With coma
0.161 0.839 0.000
E10.6 With other specified complications
0.132 0.867 0.000
H36.0 Diabetic retinopathy
0.109 0.891 0.000
N42.8 Other specified disorders of prostate
0.000 0.912 0.088
Chapter IV Endocrine, nutritional and metabolic diseases
0.086 0.914 0.000
N42 Other disorders of prostate
0.000 0.914 0.086
N40-N51 Diseases of male genital organs
0.000 0.916 0.084
E20-E35 Disorders of other endocrine glands
0.083 0.917 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.921 0.079
N42.1 Congestion and haemorrhage of prostate
0.000 0.922 0.078
E23 Hypofunction and other disorders of pituitary gland
0.077 0.923 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.923 0.077
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.926 0.074
E27 Other disorders of adrenal gland
0.074 0.926 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.927 0.073
E29 Testicular dysfunction
0.073 0.927 0.000
N41 Inflammatory diseases of prostate
0.000 0.927 0.073
E22 Hyperfunction of pituitary gland
0.072 0.928 0.000
E00-E07 Disorders of thyroid gland
0.071 0.929 0.000
E23.0 Hypopituitarism
0.071 0.929 0.000
T39.1 4-Aminophenol derivatives
0.000 0.930 0.070
N44 Torsion of testis
0.000 0.931 0.069
E07 Other disorders of thyroid
0.069 0.931 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.931 0.069
E07.9 Disorder of thyroid, unspecified
0.068 0.932 0.000
E24 Cushing's syndrome
0.068 0.932 0.000
E22.0 Acromegaly and pituitary gigantism
0.067 0.933 0.000
N41.1 Chronic prostatitis
0.000 0.934 0.066
E27.1 Primary adrenocortical insufficiency
0.066 0.934 0.000
E29.1 Testicular hypofunction
0.065 0.935 0.000
E23.2 Diabetes insipidus
0.064 0.936 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.936 0.064
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.937 0.063
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.937 0.063
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.938 0.062
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.938 0.062
T42.4 Benzodiazepines
0.000 0.939 0.061
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.939 0.061
T39.0 Salicylates
0.000 0.939 0.061
N51 Disorders of male genital organs in diseases classified elsewhere
0.000 0.939 0.060
E27.8 Other specified disorders of adrenal gland
0.060 0.940 0.000
N42.9 Disorder of prostate, unspecified
0.000 0.940 0.060
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.940 0.060
N42.2 Atrophy of prostate
0.000 0.940 0.060
E35 Disorders of endocrine glands in diseases classified elsewhere
0.059 0.940 0.000
E32 Diseases of thymus
0.059 0.940 0.000
E30 Disorders of puberty, not elsewhere classified
0.059 0.940 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.941 0.059
E14.9 Without complications
0.059 0.941 0.000
E20 Hypoparathyroidism
0.058 0.942 0.000
T36 Poisoning by systemic antibiotics
0.000 0.942 0.058
E34 Other endocrine disorders
0.058 0.942 0.000
E31 Polyglandular dysfunction
0.057 0.943 0.000
E40-E46 Malnutrition
0.057 0.943 0.000
E23.6 Other disorders of pituitary gland
0.057 0.943 0.000
E06 Thyroiditis
0.057 0.943 0.000
N41.9 Inflammatory disease of prostate, unspecified
0.000 0.944 0.056
E02 Subclinical iodine-deficiency hypothyroidism
0.056 0.944 0.000
E27.4 Other and unspecified adrenocortical insufficiency
0.056 0.944 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.944 0.056
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.055 0.945 0.000
E23.1 Drug-induced hypopituitarism
0.055 0.945 0.000
E24.9 Cushing's syndrome, unspecified
0.055 0.945 0.000
T43.9 Psychotropic drug, unspecified
0.000 0.945 0.055
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.945 0.055
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.945 0.055
E29.9 Testicular dysfunction, unspecified
0.055 0.945 0.000
E24.8 Other Cushing's syndrome
0.055 0.945 0.000
E27.2 Addisonian crisis
0.055 0.945 0.000
E22.9 Hyperfunction of pituitary gland, unspecified
0.054 0.946 0.000
T39.4 Antirheumatics, not elsewhere classified
0.000 0.946 0.054
T39.2 Pyrazolone derivatives
0.000 0.946 0.054
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.946 0.053
E27.5 Adrenomedullary hyperfunction
0.053 0.947 0.000
E27.0 Other adrenocortical overactivity
0.053 0.947 0.000
N42.3 Dysplasia of prostate
0.000 0.947 0.053
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.947 0.053
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.947 0.053
E29.8 Other testicular dysfunction
0.052 0.947 0.000
E29.0 Testicular hyperfunction
0.052 0.947 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.052 0.947 0.000
N41.3 Prostatocystitis
0.000 0.948 0.052
N41.2 Abscess of prostate
0.000 0.948 0.052
E25 Adrenogenital disorders
0.052 0.948 0.000
N49 Inflammatory disorders of male genital organs, not elsewhere classified
0.000 0.948 0.052
E23.7 Disorder of pituitary gland, unspecified
0.052 0.948 0.000
E22.8 Other hyperfunction of pituitary gland
0.052 0.948 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.051 0.949 0.000
E00 Congenital iodine-deficiency syndrome
0.051 0.949 0.000
E27.9 Disorder of adrenal gland, unspecified
0.051 0.949 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.051 0.949 0.000
T50.4 Drugs affecting uric acid metabolism
0.000 0.949 0.051
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.949 0.051
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.949 0.051
T43.6 Psychostimulants with abuse potential
0.000 0.950 0.050
E06.3 Autoimmune thyroiditis
0.050 0.950 0.000
T50.8 Diagnostic agents
0.000 0.950 0.049
E07.1 Dyshormogenetic goitre
0.049 0.950 0.000
E07.0 Hypersecretion of calcitonin
0.049 0.950 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.951 0.049
T38.1 Thyroid hormones and substitutes
0.000 0.951 0.049
M10.99 Gout, unspecified (Site unspecified)
0.000 0.951 0.049
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.951 0.049
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.049 0.951 0.000
E24.3 Ectopic ACTH syndrome
0.049 0.951 0.000
E24.1 Nelson's syndrome
0.049 0.951 0.000
N41.0 Acute prostatitis
0.000 0.951 0.049
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.951 0.048
E27.3 Drug-induced adrenocortical insufficiency
0.048 0.952 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.952 0.048
T36.0 Penicillins
0.000 0.952 0.048
E24.0 Pituitary-dependent Cushing's disease
0.047 0.952 0.000
E34.0 Carcinoid syndrome
0.047 0.953 0.000
E28 Ovarian dysfunction
0.047 0.953 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.953 0.047
E07.8 Other specified disorders of thyroid
0.047 0.953 0.000
H36 Retinal disorders in diseases classified elsewhere
0.047 0.953 0.000
N41.8 Other inflammatory diseases of prostate
0.000 0.953 0.047
N46 Male infertility
0.000 0.953 0.046
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.954 0.046
T50.7 Analeptics and opioid receptor antagonists
0.000 0.954 0.046
T50.5 Appetite depressants
0.000 0.954 0.046
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.954 0.046
T50.1 Loop [high-ceiling] diuretics
0.000 0.954 0.046
T50.0 Mineralocorticoids and their antagonists
0.000 0.954 0.046
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.954 0.046
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.954 0.046
T42.3 Barbiturates
0.000 0.954 0.046
T42.2 Succinimides and oxazolidinediones
0.000 0.954 0.046
E06.5 Other chronic thyroiditis
0.045 0.954 0.000
T43.2 Other and unspecified antidepressants
0.000 0.954 0.046
T47.0 Histamine H(2)-receptor antagonists
0.000 0.955 0.045
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.955 0.045
T42.0 Hydantoin derivatives
0.000 0.955 0.045
T38.9 Other and unspecified hormone antagonists
0.000 0.955 0.044
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.955 0.044
T38.7 Androgens and anabolic congeners
0.000 0.955 0.044
T38.5 Other oestrogens and progestogens
0.000 0.955 0.044
T38.4 Oral contraceptives
0.000 0.955 0.044
T38.2 Antithyroid drugs
0.000 0.955 0.044
T38.0 Glucocorticoids and synthetic analogues
0.000 0.955 0.044
E24.2 Drug-induced Cushing's syndrome
0.044 0.956 0.000
E20.8 Other hypoparathyroidism
0.044 0.956 0.000
N51.8 Other disorders of male genital organs in diseases classified elsewhere
0.000 0.956 0.043
N51.2 Balanitis in diseases classified elsewhere
0.000 0.956 0.043
N51.1 Disorders of testis and epididymis in diseases classified elsewhere
0.000 0.956 0.043
N51.0 Disorders of prostate in diseases classified elsewhere
0.000 0.956 0.043
N42.0 Calculus of prostate
0.000 0.956 0.043
E26 Hyperaldosteronism
0.043 0.956 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.957 0.043
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.957 0.043
T47.7 Emetics
0.000 0.957 0.043
T47.6 Antidiarrhoeal drugs
0.000 0.957 0.043
T47.5 Digestants
0.000 0.957 0.043
T47.4 Other laxatives
0.000 0.957 0.043
T47.3 Saline and osmotic laxatives
0.000 0.957 0.043
E30.9 Disorder of puberty, unspecified
0.043 0.957 0.000
E30.8 Other disorders of puberty
0.043 0.957 0.000
E30.1 Precocious puberty
0.043 0.957 0.000
E30.0 Delayed puberty
0.043 0.957 0.000
E32.9 Disease of thymus, unspecified
0.043 0.957 0.000
E32.8 Other diseases of thymus
0.043 0.957 0.000
E32.1 Abscess of thymus
0.043 0.957 0.000
E32.0 Persistent hyperplasia of thymus
0.043 0.957 0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.043 0.957 0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.043 0.957 0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.043 0.957 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.957 0.043
E34.8 Other specified endocrine disorders
0.042 0.958 0.000
E34.3 Short stature, not elsewhere classified
0.042 0.958 0.000
T47.2 Stimulant laxatives
0.000 0.958 0.042
E20.1 Pseudohypoparathyroidism
0.042 0.958 0.000
E20.0 Idiopathic hypoparathyroidism
0.042 0.958 0.000
T36.9 Systemic antibiotic, unspecified
0.000 0.958 0.042
T36.8 Other systemic antibiotics
0.000 0.958 0.042
T36.7 Antifungal antibiotics, systemically used
0.000 0.958 0.042
T36.6 Rifamycins
0.000 0.958 0.042
T36.5 Aminoglycosides
0.000 0.958 0.042
T36.4 Tetracyclines
0.000 0.958 0.042
T36.3 Macrolides
0.000 0.958 0.042
T36.2 Chloramphenicol group
0.000 0.958 0.042
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.958 0.042
E34.5 Androgen resistance syndrome
0.041 0.958 0.000
E34.4 Constitutional tall stature
0.041 0.958 0.000
E34.2 Ectopic hormone secretion, not elsewhere classified
0.041 0.958 0.000
E34.1 Other hypersecretion of intestinal hormones
0.041 0.958 0.000
E31.9 Polyglandular dysfunction, unspecified
0.041 0.959 0.000
E31.8 Other polyglandular dysfunction
0.041 0.959 0.000
E31.1 Polyglandular hyperfunction
0.041 0.959 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.041 0.959 0.000
E45 Retarded development following protein-energy malnutrition
0.041 0.959 0.000
E43 Unspecified severe protein-energy malnutrition
0.041 0.959 0.000
E42 Marasmic kwashiorkor
0.041 0.959 0.000
E41 Nutritional marasmus
0.041 0.959 0.000
E40 Kwashiorkor
0.041 0.959 0.000
E06.4 Drug-induced thyroiditis
0.041 0.959 0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.041 0.959 0.000
E06.1 Subacute thyroiditis
0.041 0.959 0.000
E06.0 Acute thyroiditis
0.041 0.959 0.000
E04 Other non-toxic goitre
0.041 0.959 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.960 0.040
T48.5 Anti-common-cold drugs
0.000 0.960 0.040
T48.4 Expectorants
0.000 0.960 0.040
T48.3 Antitussives
0.000 0.960 0.040
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.960 0.040
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.960 0.040
T48.0 Oxytocic drugs
0.000 0.960 0.040
E22.1 Hyperprolactinaemia
0.039 0.960 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.960 0.039
E31.0 Autoimmune polyglandular failure
0.039 0.961 0.000
E20.9 Hypoparathyroidism, unspecified
0.039 0.961 0.000
N49.8 Inflammatory disorders of other specified male genital organs
0.000 0.961 0.039
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.961 0.038
T37.5 Antiviral drugs
0.000 0.961 0.038
T37.4 Anthelminthics
0.000 0.961 0.038
T37.3 Other antiprotozoal drugs
0.000 0.961 0.038
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.961 0.038
T37.1 Antimycobacterial drugs
0.000 0.961 0.038
T37.0 Sulphonamides
0.000 0.961 0.038
T41.5 Therapeutic gases
0.000 0.962 0.038
T41.4 Anaesthetic, unspecified
0.000 0.962 0.038
T41.3 Local anaesthetics
0.000 0.962 0.038
T41.2 Other and unspecified general anaesthetics
0.000 0.962 0.038
T41.1 Intravenous anaesthetics
0.000 0.962 0.038
T41.0 Inhaled anaesthetics
0.000 0.962 0.038
T49.9 Topical agent, unspecified
0.000 0.962 0.038
T49.8 Other topical agents
0.000 0.962 0.038
T49.7 Dental drugs, topically applied
0.000 0.962 0.038
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.962 0.038
T49.5 Ophthalmological drugs and preparations
0.000 0.962 0.038
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.962 0.038
T49.3 Emollients, demulcents and protectants
0.000 0.962 0.038
T49.2 Local astringents and local detergents
0.000 0.962 0.038
T49.1 Antipruritics
0.000 0.962 0.038
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.962 0.038
E15 Nondiabetic hypoglycaemic coma
0.038 0.962 0.000
N45 Orchitis and epididymitis
0.000 0.962 0.038
E25.9 Adrenogenital disorder, unspecified
0.037 0.962 0.000
E25.8 Other adrenogenital disorders
0.037 0.962 0.000
N49.9 Inflammatory disorder of unspecified male genital organ
0.000 0.962 0.037
N49.1 Inflammatory disorders of spermatic cord, tunica vaginalis and vas deferens
0.000 0.962 0.037
N49.0 Inflammatory disorders of seminal vesicle
0.000 0.962 0.037
E50-E64 Other nutritional deficiencies
0.037 0.963 0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.037 0.963 0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.037 0.963 0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.037 0.963 0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.037 0.963 0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.037 0.963 0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.037 0.963 0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.037 0.963 0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.037 0.963 0.000
C54.1 Endometrium
0.000 0.963 0.037
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.963 0.036
E46 Unspecified protein-energy malnutrition
0.036 0.964 0.000
T42.1 Iminostilbenes
0.000 0.965 0.035
E03 Other hypothyroidism
0.035 0.965 0.000
E28.9 Ovarian dysfunction, unspecified
0.034 0.966 0.000
E28.8 Other ovarian dysfunction
0.034 0.966 0.000
E28.1 Androgen excess
0.034 0.966 0.000
E28.0 Oestrogen excess
0.034 0.966 0.000
T45.0 Antiallergic and antiemetic drugs
0.000 0.966 0.034
E04.0 Non-toxic diffuse goitre
0.034 0.966 0.000
H36.8 Other retinal disorders in diseases classified elsewhere
0.034 0.966 0.000
E65-E68 Obesity and other hyperalimentation
0.034 0.966 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.967 0.033
T45.8 Other primarily systemic and haematological agents
0.000 0.967 0.033
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.967 0.033
T45.6 Fibrinolysis-affecting drugs
0.000 0.967 0.033
T45.4 Iron and its compounds
0.000 0.967 0.033
T45.3 Enzymes, not elsewhere classified
0.000 0.967 0.033
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.967 0.033
E05 Thyrotoxicosis [hyperthyroidism]
0.032 0.968 0.000
M10.9 Gout, unspecified
0.000 0.968 0.032
E26.8 Other hyperaldosteronism
0.031 0.969 0.000
E26.1 Secondary hyperaldosteronism
0.031 0.969 0.000
T45.2 Vitamins, not elsewhere classified
0.000 0.969 0.031
E26.9 Hyperaldosteronism, unspecified
0.031 0.969 0.000
M85.89 Other specified disorders of bone density and structure (Site unspecified)
0.031 0.969 0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.030 0.969 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.970 0.030
E04.2 Non-toxic multinodular goitre
0.030 0.970 0.000
E28.2 Polycystic ovarian syndrome
0.030 0.970 0.000
E44.1 Mild protein-energy malnutrition
0.030 0.970 0.000
E44.0 Moderate protein-energy malnutrition
0.030 0.970 0.000
E04.8 Other specified non-toxic goitre
0.029 0.971 0.000
E03.8 Other specified hypothyroidism
0.029 0.971 0.000
T45.5 Anticoagulants
0.000 0.971 0.029
N43 Hydrocele and spermatocele
0.000 0.971 0.029
E16 Other disorders of pancreatic internal secretion
0.028 0.972 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.028 0.972 0.000
E28.3 Primary ovarian failure
0.028 0.972 0.000
E58 Dietary calcium deficiency
0.027 0.972 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.027 0.973 0.000
E63 Other nutritional deficiencies
0.027 0.973 0.000
E50 Vitamin A deficiency
0.027 0.973 0.000
E60 Dietary zinc deficiency
0.027 0.973 0.000
E59 Dietary selenium deficiency
0.027 0.973 0.000
E54 Ascorbic acid deficiency
0.027 0.973 0.000
E52 Niacin deficiency [pellagra]
0.027 0.973 0.000
E34.9 Endocrine disorder, unspecified
0.027 0.973 0.000
N49.2 Inflammatory disorders of scrotum
0.000 0.973 0.027
E56 Other vitamin deficiencies
0.026 0.974 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.974 0.026
N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess
0.000 0.974 0.026
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.974 0.026
M10.93 Gout, unspecified (Forearm)
0.000 0.975 0.025
E05.0 Thyrotoxicosis with diffuse goitre
0.025 0.975 0.000
E03.1 Congenital hypothyroidism without goitre
0.025 0.975 0.000
E03.5 Myxoedema coma
0.025 0.975 0.000
E03.4 Atrophy of thyroid (acquired)
0.025 0.975 0.000
E03.3 Postinfectious hypothyroidism
0.025 0.975 0.000
E53 Deficiency of other B group vitamins
0.025 0.975 0.000
E05.8 Other thyrotoxicosis
0.025 0.975 0.000
M10.97 Gout, unspecified (Ankle and foot)
0.000 0.975 0.025
E51 Thiamine deficiency
0.024 0.975 0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.024 0.975 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.024 0.976 0.000
E04.1 Non-toxic single thyroid nodule
0.024 0.976 0.000
E67 Other hyperalimentation
0.024 0.976 0.000
E68 Sequelae of hyperalimentation
0.024 0.976 0.000
E06.9 Thyroiditis, unspecified
0.023 0.976 0.000
M10.92 Gout, unspecified (Upper arm)
0.000 0.976 0.024
M10.90 Gout, unspecified (Multiple sites)
0.000 0.976 0.024
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.977 0.023
E55 Vitamin D deficiency
0.023 0.977 0.000
E05.5 Thyroid crisis or storm
0.023 0.977 0.000
E05.4 Thyrotoxicosis factitia
0.023 0.977 0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.023 0.977 0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.023 0.977 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.977 0.023
M10.98 Gout, unspecified (Other)
0.000 0.977 0.023
M10.95 Gout, unspecified (Pelvic region and thigh)
0.000 0.977 0.023
M10.91 Gout, unspecified (Shoulder region)
0.000 0.977 0.023
E03.0 Congenital hypothyroidism with diffuse goitre
0.023 0.977 0.000
M10.94 Gout, unspecified (Hand)
0.000 0.977 0.023
E53.9 Vitamin B deficiency, unspecified
0.022 0.978 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.978 0.022
T46.7 Peripheral vasodilators
0.000 0.978 0.022
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.978 0.022
E21.2 Other hyperparathyroidism
0.022 0.978 0.000
N43.1 Infected hydrocele
0.000 0.978 0.021
M85.8 Other specified disorders of bone density and structure
0.021 0.979 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.979 0.021
M80.98 Unspecified osteoporosis with pathological fracture (Other)
0.000 0.979 0.021
N43.0 Encysted hydrocele
0.000 0.979 0.021
E16.9 Disorder of pancreatic internal secretion, unspecified
0.020 0.979 0.000
E16.8 Other specified disorders of pancreatic internal secretion
0.020 0.979 0.000
E16.4 Abnormal secretion of gastrin
0.020 0.979 0.000
E16.3 Increased secretion of glucagon
0.020 0.979 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.979 0.020
E21.4 Other specified disorders of parathyroid gland
0.020 0.980 0.000
E10.9 Without complications
0.020 0.980 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.980 0.019
E61 Deficiency of other nutrient elements
0.020 0.980 0.000
M10.96 Gout, unspecified (Lower leg)
0.000 0.980 0.020
M85.80 Other specified disorders of bone density and structure (Multiple sites)
0.020 0.980 0.000
E65 Localised adiposity
0.020 0.980 0.000
E50.9 Vitamin A deficiency, unspecified
0.019 0.980 0.000
E50.8 Other manifestations of vitamin A deficiency
0.019 0.980 0.000
E50.7 Other ocular manifestations of vitamin A deficiency
0.019 0.980 0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.019 0.980 0.000
E50.5 Vitamin A deficiency with night blindness
0.019 0.980 0.000
E50.4 Vitamin A deficiency with keratomalacia
0.019 0.980 0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.019 0.980 0.000
E50.2 Vitamin A deficiency with corneal xerosis
0.019 0.980 0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.019 0.980 0.000
E50.0 Vitamin A deficiency with conjunctival xerosis
0.019 0.980 0.000
E63.9 Nutritional deficiency, unspecified
0.019 0.980 0.000
E63.8 Other specified nutritional deficiencies
0.019 0.980 0.000
E63.1 Imbalance of constituents of food intake
0.019 0.980 0.000
E63.0 Essential fatty acid [EFA] deficiency
0.019 0.980 0.000
E64.9 Sequelae of unspecified nutritional deficiency
0.019 0.980 0.000
E64.8 Sequelae of other nutritional deficiencies
0.019 0.980 0.000
E64.3 Sequelae of rickets
0.019 0.980 0.000
E64.2 Sequelae of vitamin C deficiency
0.019 0.980 0.000
E64.1 Sequelae of vitamin A deficiency
0.019 0.980 0.000
E64.0 Sequelae of protein-energy malnutrition
0.019 0.980 0.000
N43.4 Spermatocele
0.000 0.980 0.019
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.980 0.019
N50 Other disorders of male genital organs
0.000 0.981 0.019
E21.5 Disorder of parathyroid gland, unspecified
0.019 0.981 0.000
E56.9 Vitamin deficiency, unspecified
0.019 0.981 0.000
E56.8 Deficiency of other vitamins
0.019 0.981 0.000
E56.0 Deficiency of vitamin E
0.019 0.981 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.981 0.019
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.981 0.019
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.981 0.019
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.981 0.019
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.981 0.019
T44.0 Anticholinesterase agents
0.000 0.981 0.019
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.981 0.019
T40.8 Lysergide [LSD]
0.000 0.981 0.019
T40.7 Cannabis (derivatives)
0.000 0.981 0.019
T40.3 Methadone
0.000 0.981 0.019
T40.1 Heroin
0.000 0.981 0.019
T40.0 Opium
0.000 0.981 0.019
E56.1 Deficiency of vitamin K
0.018 0.981 0.000
E53.1 Pyridoxine deficiency
0.018 0.982 0.000
E53.0 Riboflavin deficiency
0.018 0.982 0.000
E51.9 Thiamine deficiency, unspecified
0.018 0.982 0.000
E51.8 Other manifestations of thiamine deficiency
0.018 0.982 0.000
E51.1 Beriberi
0.018 0.982 0.000
E67.8 Other specified hyperalimentation
0.017 0.982 0.000
E67.3 Hypervitaminosis D
0.017 0.982 0.000
E67.2 Megavitamin-B6 syndrome
0.017 0.982 0.000
E67.1 Hypercarotenaemia
0.017 0.982 0.000
E67.0 Hypervitaminosis A
0.017 0.982 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.982 0.017
T40.5 Cocaine
0.000 0.983 0.017
E55.0 Rickets, active
0.017 0.983 0.000
E21.0 Primary hyperparathyroidism
0.017 0.983 0.000
N43.2 Other hydrocele
0.000 0.983 0.017
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.984 0.016
M85.81 Other specified disorders of bone density and structure (Shoulder region)
0.016 0.984 0.000
E26.0 Primary hyperaldosteronism
0.015 0.984 0.001
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.984 0.016
E51.2 Wernicke's encephalopathy
0.015 0.984 0.000
M85.84 Other specified disorders of bone density and structure (Hand)
0.015 0.985 0.000
M85.82 Other specified disorders of bone density and structure (Upper arm)
0.015 0.985 0.000
T40.6 Other and unspecified narcotics
0.000 0.985 0.015
C50.8 Overlapping lesion of breast
0.000 0.985 0.015
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.015 0.985 0.000
T40.2 Other opioids
0.000 0.985 0.015
M10 Gout
0.000 0.985 0.015
M85.87 Other specified disorders of bone density and structure (Ankle and foot)
0.015 0.985 0.000
M85.85 Other specified disorders of bone density and structure (Pelvic region and thigh)
0.014 0.985 0.000
E61.9 Deficiency of nutrient element, unspecified
0.014 0.985 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.